Department of Medicine
Faculty Profiles by Division

Department of Medicine

Faculty Profiles

[Return To Index page]
photo Kailey Hughes Kramer, PhD

Infectious Diseases

Director, Clinical Research Translational Research Unit (TRU)

Director, Infectious Diseases Expanded Access (IDEA) Center

Email: hugheskl4@upmc.edu

Phone: 412-648-6453

Contact
Office: 3601 Fifth Avenue
Falk Medical Building, Suite 5B
Pittsburgh, PA 15213
 
Phone: 412-648-6453
Fax: 412-648-6399
E-mail: hugheskl4@upmc.edu
Education and Training
Education
PhD, Epidemiology, University of Pittsburgh, School of Public Health, 2023
MPH, Epidemiology, University of Pittsburgh, School of Public Health, 2017
BA, Biology, University of Delaware, 2014
Research Interest
Dr. Hughes Kramer's research focuses on respiratory viruses and vaccine effectiveness in immunocompromised adults. In addition to her own research, Dr. Hughes Kramer oversees the Translational Research Unit (TRU) Clinical Research.
Clinical Interest
Dr. Hughes Kramer is the Director of the Infectious Diseases Expanded Access (IDEA) center. In this role, she oversees all compassionate use, emergency investigational new drug (eIND), and single patient investigational new drug (SPIND) applications for the Division of Infectious Diseases. The IDEA Center has allowed physicians to access medications and biologics such as clofazimine, fosmanogepix, olorofim, SARS-CoV-2 T cells, and bacteriophages.
Educational Interest
Dr. Hughes Kramer mentors public health graduate students interested in clinical infectious disease research through summer internships, masters essay committees, and the TRU student research assistant program. She gives lectures on infectious disease epidemiology and vaccine efficacy and effectiveness. Additionally, she is an adjunct professor at Duquesne University where she teaches the Introduction to Epidemiology course to undergraduates.
Publications
Selected Publications:
Hughes, K., Middleton, D.B., Nowalk, M.P., et al. Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults. Clinical Infectious Diseases. 2021; 73(11): e4353-e4360.
Haidar, G., Jacobs, J. L., Hughes Kramer, K., et al. Therapy with Allogeneic SARS-CoV-2-specific Tcells for Persistent COVID-19 in Immunocompromised Patients. Clinical Infectious Diseases. 2023; Epub Apr 20.
Luciani, L. L., Miller, L. M., Zhai, B., Clarke, K., Hughes Kramer, K., Schratz, L. J., Balasubramani, G. K., Dauer, K., Nowalk, M. P., Zimmerman, R. K., Shoemaker, J. E., Alcorn, J. F. Blood Inflammatory Biomarkers Differentiate Inpatient and Outpatient Coronavirus Disease 2019 From Influenza. Open Forum Infectious Diseases. 2023; 10(3): ofa095.
Notable Achievements
UPMC Award for Commitment and Excellence (ACES) Recipient, 2021
Pittsburgh Business Times 30 Under 30 Award Recipient, 2022